{"disease":{"id":"ebv-infection","name":"ebv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03491605","title":"Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05682703","title":"A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05978141","title":"A Registry for People With T-cell Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06908096","title":"Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04189835","title":"EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":509,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05604378","title":"Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis","phase":"","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"Saint Vincent's Hospital, Korea","has_results":false},{"nct_id":"NCT03159364","title":"Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT04308278","title":"Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Labo'Life","has_results":false},{"nct_id":"NCT04645147","title":"Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":83,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03475212","title":"Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Pediatric Transplantation & Cellular Therapy Consortium","has_results":false},{"nct_id":"NCT04084626","title":"PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05039580","title":"Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06789159","title":"A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT07133776","title":"Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false},{"nct_id":"NCT06075927","title":"Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04690036","title":"PD-1 Antibody for Reactive EBV After BMT","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07261215","title":"Zuberitamab for EBV Infection Post-Allo-HSCT","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07476014","title":"Early Clinical Study on the Use of Donor-derived EBV-specific T Cells for the Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06491719","title":"A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06119256","title":"Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06135922","title":"Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06689397","title":"Investigating Epstein-Barr Virus Associated Conjunctivitis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT02822495","title":"Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false},{"nct_id":"NCT01945619","title":"Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}